Advertisement




Cancer Diagnosis Was A Surprise To Megadeth Cofounder 2019 In Review

William Lee | 12-30-2019

Cancer Diagnosis Was A Surprise To Megadeth Cofounder was a top 19 story of July 2019: Megadeth frontman Dave Mustaine's cancer diagnosis came as a surprise to band co-founder David Ellefson, who says that there were no apparent symptoms that caused any concern.

Mustaine revealed the throat cancer news to fans last month and during a SiriusXM appearance, Ellefson was asked is he knew of any health issues before the diagnosis and he replied, "No. Not at all. In fact, that's why it was very surprising, even to him. One thing he said, 'Hey, you should go checked too.'

"I don't know how they discovered it... I was in Europe doing stuff [earlier in the year when Mustaine was taking part in the 'Experience Hendrix' [tour]. But, obviously, we were communicating; we were working on writing a record; we were sending files back and forth and stuff. For me, and for the [rest of] the band, it really came to light while we were down [in Nashville] working on the record.

"And once [Mustaine] got a treatment plan in place, that's when the decision was made, 'Clear the decks.' And, really, that wiped the entire fall off the entire calendar - except the [band's upcoming Megacruise]."


Advertisement




Related Stories

Megadeth, Arizona Resurrected For 'Youthanasia' 30th Anniversary

Singled Out: Cathy Rankin's Now You've Gone' (Tribute To Neil Peart)

Cathy Rankin Recruits Megadeth and Alice Cooper Stars For Neil Peart Tribute

Megadeth Vow To 'Be Back' Following Destroy All Enemies Tour

Why Megadeth Cancelled Concert At Last Minute

News Reports
Day in Rock: Three Days Grace Share First Adam Gontier Reunion Song 'Mayday'- Twenty On Pilots Share 'The Line' From Arcane League of Legends: Season 2 Soundtrack- more

Journey Icon Steve Perry Shares Video For Duet With His Late Father- Green Day, Post Malone and Lady Gaga Lead Coachella Lineup- more


Contact Us - Privacy

Copyright 2023 Iconoclast Entertainment Group All rights reserved.